Search

everythinglearnresearchcommunity

for

Search:↓

A new microneedle treatment shows promise for better hair regrowth in androgenetic alopecia.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Measuring 24-OHase induction helps identify defects in vitamin D processing and predict treatment response.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

TCHHL1 is a protein important for hair growth, found in hair follicles.

A new compound shows promise as a topical treatment for hair loss.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

MK-386 lowers DHT in blood and skin but not in semen.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Male cells need DHT to respond to testosterone, while female cells do not.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

In India, most patients with type 1 autoimmune polyglandular failure show symptoms in a specific order, starting with parathyroid gland issues, then yeast infections, and finally adrenal gland failure.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.